Fundraising FoxGeniPhys
Indianapolis, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into GeniPhys
Sign up to see every warm intro you have to GeniPhys
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GeniPhys team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GeniPhys develops Collymer, a patented polymerizable (scaffold-forming) collagen technology used to design and fabricate collagen biomaterials for tissue restoration and regeneration. Its materials target regenerative medicine applications including soft tissue, cardiovascular, musculoskeletal, and orthopedic replacements, as well as delivery of pharmaceutical and cell-based therapies and device coatings.
Founders & leadership
GeniPhys was founded in 2021 by Sherry Harbin.
Board
Investors · 1
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7.5M disclosed across 2 rounds · 2022–2026
▶$3MraisedFeb 2026 · 17 investors · Other Health CareRule 506(b)
- John DeFordDirector
- Shaun HawkinsDirector
- Andrew S EiblingExecutive Officer, Director
- R. Matthew NeffDirector
- Offering amount
- $5.5M
- Amount sold
- $3M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$4.5MraisedNov 2022 · 25 investors · Other Health CareRule 506(b)
- Sherry L. HarbinExecutive Officer, Director
- Scot A. HarbinExecutive Officer
- R. Matthew NeffDirector
- Andrew S. EiblingExecutive Officer, Director
- Offering amount
- $6.1M
- Amount sold
- $4.5M
- Minimum investment
- $25K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does GeniPhys do?
- GeniPhys develops Collymer, a patented polymerizable (scaffold-forming) collagen technology used to design and fabricate collagen biomaterials for tissue restoration and regeneration. Its materials target regenerative medicine applications including soft tissue, cardiovascular, musculoskeletal, and orthopedic replacements, as well as delivery of pharmaceutical and cell-based therapies and device coatings.
- Who founded GeniPhys?
- GeniPhys was founded by Sherry Harbin in 2021.
- Who are GeniPhys's investors?
- GeniPhys's investors include Elevate Ventures.
- How much funding has GeniPhys raised?
- GeniPhys has disclosed $7.5M raised across 2 rounds.
- Where is GeniPhys headquartered?
- GeniPhys is headquartered in Indianapolis, US.